Filter Options
-
AdventHealth Celebration is Among First in the State to Offer Non-invasive Histotripsy Treatment for Unresectable Liver Tumors
Hepato-pancreato-biliary (HPB) surgeon Andrew Guzowski, MD, performed AdventHealth’s first liver histotripsy, a non-invasive treatment for certain patients with unresectable liver tumors.
-
AdventHealth for Children Recruiting Patients with Fabry Disease for Phase III PERIDOT Clinical Trial Evaluating a Potential New Treatment Option
Under the leadership of Medical Director of Genomics and Personalized Health Majed Dasouki, MD, AdventHealth for Children is recruiting patients for a new Phase III clinical trial to evaluate the...
-
Harnessing Music’s Healing Power for Stroke Survivors in Central Florida
Explore the healing power of music for stroke survivors and their families in this episode of the Inspiring Wholeness podcast.
-
Chief Clinical Officer Appointed to Serve the AdventHealth East Florida Division
Dr. Andrew Weinfeld will be responsible for executing clinical and organizational strategy, improving clinical effectiveness and patient safety, and delivering exceptional patient experiences for the...
-
Lessons Learned — Creating a Health Care Culture That Accelerates Improvement
In 1999, the Institute of Medicine Committee on Quality of Health Care in America released a pivotal report titled, “To Err is Human: Building a Safer Health System” in an effort to break the silence...
-
AdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome
Under the leadership of principal investigator Ki Hyeong Lee, MD, MS, medical director of AdventHealth for Children’s pediatric epilepsy center in Orlando, AdventHealth Orlando has been one of two...
-
AdventHealth for Children Collaborating with n-Lorem Foundation to Provide Personalized Treatments to Patients with Nano-rare Genetic Diseases
The n-Lorem Foundation recently selected AdventHealth for Children in Orlando as one of the first institutions in Florida to collaborate with providing personalized antisense oligonucleotide (ASO)...
-
AdventHealth Neuroscience Institute Secures New Gamma Knife Radiosurgery Platform to Advance Patient Care
In April 2024, the AdventHealth Neuroscience Institute became the first in Central Florida to treat brain patients with the Elekta Esprit Gamma Knife. This advanced stereotactic radiosurgery (SRS)...
-
Innovative Spring Sees Three Groundbreaking Cardiovascular Procedures Performed by AdventHealth Physicians
This spring, AdventHealth marked significant advancements in patient care with three “firsts” representing a leap forward in treatment of cardiovascular conditions.
-
Three Disruptive Clinical Innovations Could Shape the Next Decade in Health Care
From a rapidly growing population in need of our services to a shrinking workforce under increased stress, health care systems across the nation face access challenges that will impact our work for...
-
AdventHealth Orlando is the First in Central Florida to Randomize a Patient in the Global ALLAY-HF Study for Alleviating Heart Failure Symptoms
Under the leadership of AdventHealth Heart, Lung and Vascular Institute interventional cardiologist Rohit Bhatheja, MD, MBA, FACC, FSCAI, AdventHealth Orlando became the first in Central Florida to...
-
Groundbreaking Ozempic study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney Disease
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
-
Pro Volleyball in Central Florida and Breaking Barriers for Female Athletes
In this episode of the Inspiring Wholeness podcast, Orlando Valkyries head coach Amy Pauly talks with Dr. Nicole Wilson, a Rothman Orthopaedics sports medicine physician at AdventHealth, about...